PTPN1 and type 2 diabetes mellitus: Previous research has reported phenotypes with enhanced sensitivity to insulin and lower plasma glucose and insulin levels in PTP1B knockout mice, which implies that PTP1B is an attractive therapeutic target for T2DM [4,5].